Fine-needle biopsy of metastatic melanoma: Clinical use and new applications

The Lancet Oncology

Volumn 11, Issue 4, 2010, Pages 391-400

  Murali, Rajmohan ^a,b,c   Thompson, John F ^b,c   Uren, Roger F ^c   Scolyer, Richard A ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100;

CANCER MORPHOLOGY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE;

BIOPSY, FINE-NEEDLE; DIAGNOSTIC ERRORS; HUMANS; MELANOMA; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 77950315413     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70332-8     Document Type: Review

References (66)

1. Thompson JF, Scolyer RA, Kefford RF Cutaneous melanoma. Lancet 2005, 365:687-701.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
3. Garbe C, Leiter U Melanoma epidemiology and trends. Clin Dermatol 2009, 27:3-9.
4. Thompson JF, Scolyer RA, Kefford RF Cutaneous melanoma in the era of molecular profiling. Lancet 2009, 374:362-365.
5. Beddingfield FC The melanoma epidemic: res ipsa loquitur. Oncologist 2003, 8:459-465.
6. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19:3622-3634.
7. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
8. Layfield LJ, Gopez E, Hirschowitz S Cost efficiency analysis for fine-needle aspiration in the workup of parotid and submandibular gland nodules. Diagn Cytopathol 2006, 34:734-738.
9. Steel BL, Schwartz MR, Ramzy I Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls. Acta Cytol 1995, 39:76-81.
10. Lussier C, Klijanienko J, Vielh P Fine-needle aspiration of metastatic nonlymphomatous tumors to the major salivary glands: a clinicopathologic study of 40 cases cytologically diagnosed and histologically correlated. Cancer 2000, 90:350-356.
11. Bofin AM, Lydersen S, Isaksen C, Hagmar BM Interpretation of fine needle aspiration cytology of the breast: a comparison of cytological, frozen section, and final histological diagnoses. Cytopathology 2004, 15:297-304.
12. Logrono R, Kurtycz DF, Sproat IA, Shalkham JE, Stewart JA, Inhorn SL Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol 1998, 18:338-342.
13. Schafer-Hesterberg G, Schoengen A, Sterry W, Voit C Use of ultrasound to early identify, diagnose and localize metastases in melanoma patients. Expert Rev Anticancer Ther 2007, 7:1707-1716.
14. Uren RF, Sanki A, Thompson JF The utility of ultrasound in patients with melanoma. Expert Rev Anticancer Ther 2007, 7:1633-1642.
15. Uren RF, Howman-Giles R, Thompson JF, et al. High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol 1999, 43:148-152.
16. Galbraith W, Marshall PN, Lee ES, Bacus JW Studies on Papanicolaou staining. I. Visible-light spectra of stained cervical cells. Anal Quant Cytol 1979, 1:160-168.
17. Marshall PN, Galbraith W, Bacus JW Studies on Papanicolaou staining. II. Quantitation of dye components bound to cervical cells. Anal Quant Cytol 1979, 1:169-178.
18. Sanchez N, Selvaggi SM Utility of cell blocks in the diagnosis of thyroid aspirates. Diagn Cytopathol 2006, 34:89-92.
19. Florell SR, Schmidt SJ, Porter-Gill P, et al. Novel application of a fibrin cell block method to evaluate melanocytic cell populations. Pigment Cell Res 2003, 16:662-669.
20. Gupta SK, Rajwanshi AK, Das DK Fine needle aspiration cytology smear patterns of malignant melanoma. Acta Cytol 1985, 29:983-988.
21. Murali R, Doubrovsky A, Watson GF, et al. Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. Am J Clin Pathol 2007, 127:385-397.
22. Kline TS, Kannan V Aspiration biopsy cytology and melanoma. Am J Clin Pathol 1982, 77:597-601.
23. Kapila K, Kharbanda K, Verma K Cytomorphology of metastatic melanoma-use of S-100 protein in the diagnosis of amelanotic melanoma. Cytopathology 1991, 2:229-237.
24. Layfield LJ, Ostrzega N Fine needle aspirate smear morphology in metastatic melanoma. Acta Cytol 1989, 33:606-612.
25. Nasiell K, Tani E, Skoog L Fine needle aspiration cytology and immunocytochemistry of metastatic melanoma. Cytopathology 1991, 2:137-147.
26. Rodrigues LK, Leong SP, Ljung BM, et al. Fine needle aspiration in the diagnosis of metastatic melanoma. J Am Acad Dermatol 2000, 42:735-740.
27. Saqi A, McGrath CM, Skovronsky D, Yu GH Cytomorphologic features of fine-needle aspiration of metastatic and recurrent melanoma. Diagn Cytopathol 2002, 27:286-290.
28. Piao Y, Guo M, Gong Y Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens. Cancer 2008, 114:94-101.
29. Fetsch PA, Filie AC, Steinberg SM, Abati A Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma. Diagn Cytopathol 2001, 25:78-79.
30. McCarthy SW, Scolyer RA, Palmer AA Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004, 36:445-451.
31. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 2004, 28:1518-1525.
32. Murali R, Loughman NT, McKenzie PR, Watson GF, Thompson JF, Scolyer RA Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma. Am J Clin Pathol 2008, 130:715-723.
33. Voit C, Mayer T, Proebstle TM, et al. Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 2000, 90:186-193.
34. Cangiarella J, Symmans WF, Shapiro RL, et al. Aspiration biopsy and the clinical management of patients with malignant melanoma and palpable regional lymph nodes. Cancer 2000, 90:162-166.
35. Basler GC, Fader DJ, Yahanda A, Sondak VK, Johnson TM The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol 1997, 36:403-408.
36. Perry MD, Seigler HF, Johnston WW Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. J Natl Cancer Inst 1986, 77:1013-1021.
37. Hafström L, Hugander A, Jonsson PE, Lindberg LG Fine-needle-aspiration cytodiagnosis of recurrent malignant melanoma. J Surg Oncol 1980, 15:229-234.
38. Dalle S, Paulin C, Lapras V, Balme B, Ronger-Savle S, Thomas L Fine-needle aspiration biopsy with ultrasound guidance in patients with malignant melanoma and palpable lymph nodes. Br J Dermatol 2006, 155:552-556.
39. Martinez F, Merenda G, Bedrossian CW Lipid-rich metastatic balloon-cell melanoma: diagnosis by a multimodal approach to aspiration biopsy cytology. Diagn Cytopathol 1990, 6:427-433.
40. Slagel DD, Raab SS, Silverman JF Fine needle aspiration biopsy of metastatic malignant melanoma with " rhabdoid" features. Frequency, cytologic features, pitfalls and ancillary studies. Acta Cytol 1997, 41:1426-1430.
41. Baloch ZW, Sack MJ, Yu GH, Gupta PK Papillary formations in metastatic melanoma. Diagn Cytopathol 1999, 20:148-151.
42. Eckert F, Baricevic B, Landthaler M, Schmid U Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings. J Am Acad Dermatol 1992, 26:870-875.
43. Elliott D, Pitman MB Malignant melanoma with a myxoid stroma: a diagnostic pitfall on fine-needle aspiration biopsy. Diagn Cytopathol 2001, 25:185-190.
44. Chorny JA, Barr RJ S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002, 24:309-312.
45. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. New Engl J Med 2006, 355:1307-1317.
46. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
47. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995, 5:255-260.
48. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000, 7:469-474.
49. Thompson JF The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 2001, 8:44S-47S.
50. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976-983.
51. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 2005, 12:18-23.
52. Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 2003, 83:80-84.
53. van Rijk MC, Teertstra HJ, Peterse JL, et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol 2006, 13:1511-1516.
54. Voit C, Kron M, Schafer G, et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2006, 13:1682-1689.
55. Voit CA, Schafer-Hesterberg G, Kron M, et al. Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival. J Clin Oncol 2008, 26:5742-5747.
56. Voit CA, van Akkooi AC, Schafer-Hesterberg G, et al. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?. J Clin Oncol 2009, 27:4994-5000.
57. Sanki A, Uren RF, Moncrieff M, et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 2009, 27:5614-5619.
58. Scolyer RA, Thompson JF, Li LX, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004, 17:1191-1197.
59. Beavis A, Dawson M, Doble P, et al. Sentinel lymph node identity confirmed by analysis of fine needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol 2008, 15:934-940.
60. Stretch JR, Somorjai R, Bourne R, et al. Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Ann Surg Oncol 2005, 12:943-949.
61. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998, 58:2170-2175.
62. Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009, 41:383-387.
63. Marincola FM, Hijazi YM, Fetsch P, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol 1996, 19:192-205.
64. Bonaldi L, Midena E, Filippi B, et al. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol 2008, 134:1123-1127.
65. Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol 2007, 125:1017-1024.
66. Young TA, Rao NP, Glasgow BJ, Moral JN, Straatsma BR Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Ophthalmology 2007, 114:142-146.